Abstract:Over the last decade, hydrogen sulfide (H2S) has emerged as an important endogenous gasotransmitter in mammalian cells and tissues. Similar to the previously characterized gasotransmitters nitric oxide and carbon monoxide, H2S is produced by various enzymatic reactions and regulates a host of physiologic and pathophysiological processes in various cells and tissues. H2S levels are decreased in a number of conditions (e.g., diabetes mellitus, ischemia, and aging) and are increased in other states (e.g., inflammation, critical illness, and cancer). Over the last decades, multiple approaches have been identified for the therapeutic exploitation of H2S, either based on H2S donation or inhibition of H2S biosynthesis. H2S donation can be achieved through the inhalation of H2S gas and/or the parenteral or enteral administration of so-called fast-releasing H2S donors (salts of H2S such as NaHS and Na2S) or slow-releasing H2S donors (GYY4137 being the prototypical compound used in hundreds of studies in vitro and in vivo). Recent work also identifies various donors with regulated H2S release profiles, including oxidant-triggered donors, pH-dependent donors, esterase-activated donors, and organelle-targeted (e.g., mitochondrial) compounds. There are also approaches where existing, clinically approved drugs of various classes (e.g., nonsteroidal anti-inflammatories) are coupled with H2S-donating groups (the most advanced compound in clinical trials is ATB-346, an H2S-donating derivative of the non-steroidal anti-inflammatory compound naproxen). For pharmacological inhibition of H2S synthesis, there are now several small molecule compounds targeting each of the three H2S-producing enzymes cystathionine-β-synthase (CBS), cystathionine-γ-lyase, and 3-mercaptopyruvate sulfurtransferase. Although many of these compounds have their limitations (potency, selectivity), these molecules, especially in combination with genetic approaches, can be instrumental for the delineation of the biologic processes involving endogenous H2S production. Moreover, some of these compounds (e.g., cell-permeable prodrugs of the CBS inhibitor aminooxyacetate, or benserazide, a potentially repurposable CBS inhibitor) may serve as starting points for future clinical translation. The present article overviews the currently known H2S donors and H2S biosynthesis inhibitors, delineates their mode of action, and offers examples for their biologic effects and potential therapeutic utility.

The Role of Host-Generated H2S in Microbial Pathogenesis: New Perspectives on Tuberculosis

Mycobacterium tuberculosis H2S Functions as a Sink to Modulate Central Metabolism, Bioenergetics, and Drug Susceptibility

Hydrogen Sulfide Dysregulates the Immune Response by Suppressing Central Carbon Metabolism to Promote Tuberculosis.

Endogenous production and physiological functions of hydrogen sulfide in facultative anaerobic bacteria

Generation and Physiology of Hydrogen Sulfide and Reactive Sulfur Species in Bacteria

The Role of Hydrogen Sulfide in Respiratory Diseases

Hydrogen sulfide in physiology and pathogenesis of bacteria and viruses

Hydrogen Sulfide: A Versatile Molecule and Therapeutic Target in Health and Diseases

New Therapeutic Approaches Using Hydrogen Sulfide Donors in Inflammation and Immune Response

Hydrogen Sulfide Biology and Its Role in Cancer

Chemistry of Hydrogen Sulfide—Pathological and Physiological Functions in Mammalian Cells

International Union of Basic and Clinical Pharmacology. CII: Pharmacological Modulation of H2S Levels: H2S Donors and H2S Biosynthesis Inhibitors

Physiological Implications of Hydrogen Sulfide: A Whiff Exploration That Blossomed

A Dual Role of Heme Oxygenase-1 in Tuberculosis

Hydrogen Sulfide and Liver Health: Insights into Liver Diseases

Hydrogen Sulfide in Biochemistry and Medicine

Mechanisms underlying the hydrogen sulfide actions — target molecules and downstream signaling pathways

The uncharted territory of host-pathogen interaction in tuberculosis

H2S-Induced Sulfhydration: Biological Function and Detection Methodology

Hydrogen sulfide-based therapeutics: exploiting a unique but ubiquitous gasotransmitter

Sulfide Homeostasis and Nitroxyl Intersect via Formation of Reactive Sulfur Species in Staphylococcus aureus